KUVATRIS THERAPEUTICS, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements
KUVATRIS THERAPEUTICS, INC. reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements of -$559.60 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2026-01-14.
Financial Statements › Notes › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements · last filed 2026-01-14
- KUVATRIS THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2023-09-30 was -$797.20K.
- KUVATRIS THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2023-06-30 was $0.00.
- KUVATRIS THERAPEUTICS, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2023-03-31 was $237.60K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 9 month as first filed |
|---|---|---|---|---|
| 2023-09-30 | -$797.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-01-14 | -$797.20K derived: sum of 2 quarters · filed 2026-01-14 | -$559.60K 10-Q · filed 2026-01-14 | $559.60K 10-Q · filed 2023-11-16 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-09-20 | $237.60K 10-Q · filed 2024-09-20 | ||
| 2023-03-31 | $237.60K 10-Q · filed 2024-05-13 |